Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens (Q42644951)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Effects of competitive and non-competitive NMDA receptor antagonists on dopamine output in the shell and core subdivisions of the nucleus accumbens (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

0 references

nucleus accumbens

1 reference

based on heuristic

inferred from title

author name string

Marcus MM

1

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Mathé JM

2

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Nomikos GG

3

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Svensson TH

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

482-490

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Phencyclidine. Physiological actions, interactions with excitatory amino acids and endogenous ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The accumbens: beyond the core-shell dichotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of an N-methyl-D-aspartate receptor agonist and its antagonist CPP on the levels of dopamine and serotonin metabolites in rat striatum collected in vivo by using a brain dialysis technique

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Noncompetitive excitatory amino acid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Model psychoses and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: role of 5-HT(2A) and alpha(1)-adrenoceptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Clinical experience with excitatory amino acid antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The topographic order of inputs to nucleus accumbens in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Electrophysiological characterization of a novel potent and orally active NMDA receptor antagonist: CGP 37849 and its ethylester CGP 39551.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Effects of phencyclidine on the spontaneous activity of monoaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Neurochemical Interactions of Competitive N-Methyl-D-Aspartate Antagonists with Dopaminergic Neurotransmission and the Cerebellar Cyclic GMP System: Functional Evidence for a Phasic Glutamatergic Control of the Nigrostriatal Dopaminergic Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Excitotoxicity and the NMDA receptor--still lethal after eight years

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Concurrent locomotor stimulation and decrease in dopamine release in rats and mice after treatment with the competitive NMDA receptor antagonists D-CPPene and CGS 19755

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The behavioral pharmacology of NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Sites for Antagonism on the N-Methyl-D-Aspartate Receptor Channel Complex

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Functional-anatomical implications of the nucleus accumbens core and shell subterritories

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2800%2900199-4

7 January 2021

Identifiers

10.1016/S0028-3908(00)00199-4

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42644951&oldid=1964402205"